Vaccines and immunoassays for acquired immune deficiency syndrome using a recombinant virus that expresses an envelope or gag hiv protein or protein or peptide products thereof
FI940457A0
Process for the preparation of oncostatin-A
US5451506A
Oncostatin M and novel compositions having anti-neoplastic activity
US5618715A
Oncostatin M and novel compositions having anti-neoplastic activity
IL103749D0
A method for production of transforming growth factor beta 2
ATA186592A
Nucleotide sequence which codes for transforming growth factor &beta2, transforming growth factor &beta2, and process and cells for the preparation thereof
ATA186492A
Nucleotide sequence coding for a transforming growth factor beta2 precursor, and transforming growth factor beta2 precursor
ATA171892A
Method for obtaining a ligand and method for suppressing the proliferation of BP50-expressing cells
FI923418A
Monoclonal antibody
US5247069A
Ligands and methods for augmenting B-cell proliferation
US5248666A
Methods for inhibiting neoplastic cell proliferation using platelet factor 4
IL99427D0
Pure 50 kilodalton b cell surface antigen
US5141742A
Vaccines against melanoma
FI911853A0
A novel diagnostically useful polypeptide, oncostatin M
CA2038978A1
Antibodies for the treatment and diagnosis of pseudomonas aeruginosa infections
ZA9102137B
Monocional antibodies that inhibit growth of kaposi's sarcoma
IE904732A1
Novel proteins with oncostatin m activity and process for their preparation"
IL96593D0
Novel proteins with oncostatin m activity and process for their preparation
ZA9009842B
Proteins with oncostatin m activity and process for their preparation
